Clinical Trials Browser

Unknown × Esophageal Neoplasms × sintilimab × Clear all

NCT06161909 2023-12-08

Postoperative Immune Maintenance Therapy for Esophageal Squamous Cell Carcinoma After Radical Resection

Phase 3 Unknown

Gastrointestinal

Esophageal Neoplasms

NCT03946969 2022-07-19

Sintilimab in Combination With Chemotherapy in Neoadjuvant Treatment of Potentially Resectable Esophageal Cancer

Phase 2 Unknown

Gastrointestinal

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms